Across unpaired analyses, matched case-control comparisons and longitudinal modelling, significant elevations in ALT, ALP and ESR were observed in individuals who developed IBDALD, including at the time of IBD diagnosis. This evidence concerns the gene GPT and inflammatory bowel disease.